Related Experiment Video
Updated: Jun 30, 2026

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
Cardiovascular effects of psychotropic drugs
1Department of Medicine, Rosalind Franklin University of Medicine and Science/The Chicago Medical School, North Chicago, Illinois, USA.
Insights
Psychotropic medications can impact heart health, particularly in psychiatric patients with higher cardiovascular disease risks. Healthcare providers must monitor patients for potential cardiac side effects and conduct thorough assessments before prescribing.
Area of Science:
- Cardiology
- Psychiatry
- Pharmacology
Background:
- Cardiovascular disease (CVD) is a leading cause of death, with psychiatric populations exhibiting higher prevalence due to lifestyle and risk factors.
- Fatal arrhythmias, such as ventricular fibrillation, contribute significantly to CVD mortality.
- Psychotropic medication's potential cardiovascular and arrhythmic effects are a concern in psychiatric patients.
Purpose of the Study:
- To review the principal classes of psychotropic medications.
- To examine the cardiovascular and arrhythmic effects of these medications.
- To inform practitioners about potential cardiac risks associated with psychotropic drug use.
Main Methods:
- Literature review utilizing Medline, Pubmed, and Cochrane databases.
- Searched for publications spanning the period from 1984 to 2005.
- Synthesized findings on psychotropic drug effects on the cardiovascular system.
Main Results:
- Psychotropic medications can exert various effects on the cardiovascular system.
- Specific drug classes may increase the risk of arrhythmias or other cardiac issues.
- Understanding these effects is crucial for patient safety.
Conclusions:
- Practitioners must be aware of psychotropic medications' cardiovascular effects, especially in vulnerable patients.
- Pre-treatment assessments including medical history, physical examination, and baseline tests are mandatory.
- Careful monitoring is essential for patients on psychotropic medications, particularly those with pre-existing cardiac conditions.
Background:
Cardiovascular disease is the leading cause of death in the general population and accounts for approximately 30% of all deaths; some of these are due to fatal arrhythmias, especially ventricular fibrillation. In a psychiatric population the prevalence of cardiovascular disease is higher than in the general population because of a different lifestyle and greater frequency of risks factors such as smoking, obesity, and increased stress. The increased prevalence of sudden death in this patient population has given rise to the question of drug-induced cardiovascular and arrhythmic effects. This article reviews the principal classes of psychotropic medications and their effects on the heart.
Methods:
The review is based on Medline, Pubmed, Cochrane, and literature searches of publications from the period 1984 to 2005.
Conclusion:
It is important for practitioners to be familiar with the possible effects of psychotropic medications on the cardiovascular system, especially in the elderly and other patients with preexisting cardiac problems. Before starting treatment with a new psychotropic medication, a careful history and physical are mandatory, and baseline liver, lipid, and kidney profiles as well as chest radiographic and electrocardiographic findings should be noted.
Related Concept Videos
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Pathophysiology of Cardiac Performance
Drug Therapy
Antianxiety Medications